Phased Rollout of Bioequivalence Testing Requirement Suggested

The Regulatory Reform Committee released on February 25th of its review details and recommendations on various amendment proposals to the Korea Pharmaceutical Affairs Law, covering the major areas such as bioequivalence testing and pharmaceutical small-unit packaging requirements.

On the proposal for compulsory bioequivalence testing, the committee recommended that the industry should invite...